Suppr超能文献

[重症医学中的跨肺指示剂法]

[Transpulmonary indicator methods in intensive medicine].

作者信息

von Spiegel T, Hoeft A

机构信息

Klinik für Anästhesiologie und Spezielle Intensivmedizin der Rheinischen Friedrich-Wilhelms-Universität Bonn.

出版信息

Anaesthesist. 1998 Mar;47(3):220-8. doi: 10.1007/s001010050550.

Abstract

The management of critically ill patients often requires an advanced hemodynamic monitoring. Beside pulmonary artery catheter (PAC) and transesophageal echocardiography (TEE) the transpulmonary indicator dilution technique (TPID) with arterial registration of the indicator dilution curves is a possible approach to get additional hemodynamic information. Being less invasive, measurements of cardiac output by transpulmonary thermodilution are as reliable as the thermodilution using a PAC. Transpulmonary thermodilution can be used even in small children. In addition, intrathoracic blood volume (ITBV) and extravascular lung water (EVLW) can be estimated. ITBV seems to be a better surrogate of cardiac filling than central venous pressure and pulmonary capillary wedge pressure. EVLW can be of special value in the fluid-management of patients with systemic inflammatory response syndrome or acute respiratory failure. By using the dye indocyanine green (ICG) as a second indicator TPID can be performed as transpulmonary double indicator dilution technique. The resulting thermodilution and dye curves are measured with a combined fiberoptic-thermistor catheter. This allows the more accurate measurement of ITBV and EVLW and in addition the assessment of total circulating blood volume and ICG-clearance. ICG-clearance serves clinically as a rapidly reacting indirect measure of liver function. As with the other methods of advanced hemodynamic monitoring the data available at present do not show a positive effect on the incidence of organ failure and mortality by monitoring critically ill patients with TPID. Before applying an advanced hemodynamic monitoring it should be asked critically which parameter is needed for the therapy-management of the individual patient. Based on this a differentiated monitoring decision has to be made.

摘要

危重症患者的管理通常需要先进的血流动力学监测。除了肺动脉导管(PAC)和经食管超声心动图(TEE)外,通过动脉记录指示剂稀释曲线的经肺指示剂稀释技术(TPID)是获取额外血流动力学信息的一种可行方法。经肺热稀释法测量心输出量的侵入性较小,与使用PAC的热稀释法一样可靠。经肺热稀释法甚至可用于小儿患者。此外,还可以估算胸腔内血容量(ITBV)和血管外肺水(EVLW)。与中心静脉压和肺毛细血管楔压相比,ITBV似乎是更好的心脏充盈指标。在全身炎症反应综合征或急性呼吸衰竭患者的液体管理中,EVLW可能具有特殊价值。通过使用染料吲哚菁绿(ICG)作为第二种指示剂,TPID可作为经肺双指示剂稀释技术来进行。通过一根组合的光纤热敏电阻导管测量得到的热稀释曲线和染料曲线。这使得能够更准确地测量ITBV和EVLW,此外还能评估总循环血容量和ICG清除率。ICG清除率在临床上可作为肝功能快速反应的间接指标。与其他先进的血流动力学监测方法一样,目前可用的数据并未显示通过TPID监测危重症患者对器官衰竭发生率和死亡率有积极影响。在应用先进的血流动力学监测之前,应审慎地考虑对于个体患者的治疗管理需要哪些参数。基于此,必须做出差异化的监测决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验